Indonesia Antidiabetics Market (2024-2030) Outlook | Revenue, Share, Forecast, Analysis, Companies, Growth, Value, Size, Industry & Trends

Market Forecast By Product (Insulin , Drug Class), By Patient Population (Paediatric, Adult, Geriatric), By Route of Administration (Insulin syringe/ Insulin pen, Insulin pump, Intravenous infusion, Oral, Others) And Competitive Landscape
Product Code: ETC131330 Publication Date: Jul 2023 Updated Date: Jan 2024 Product Type: Report
Publisher: 6Wresearch No. of Pages: 70 No. of Figures: 35 No. of Tables: 5

Indonesia Antidiabetics Market Synopsis

The Indonesia antidiabetics market is expected to witness healthy CARG in the future. Rising incidences of diabetes, increasing awareness about diabetes and its treatment, and growing investments in healthcare infrastructure are driving the growth of antidiabetic drugs in the country.

Key Factors Driving the Market

The growing prevalence of diabetes among people in Indonesia has led to an increase in demand for antidiabetic drugs over recent years. As per WHO estimates, around 10 million Indonesias suffer from type 2 diabetes (T2D). This is likely to drive the demand for antidiabetic drugs as individuals seek treatments that can control their blood sugar levels and reduce complications associated with T2D. Increasing awareness regarding lifestyle modifications and effective management strategies for controlling blood glucose levels could also be contributing to increased sales of antidiabetic products across Indonesia. Besides this, favorable government policies such as improved health insurance coverage have allowed more patients access to affordable medicines which has further boosted the demand for these drugs.

Challenges Facing the Market

Limitations regarding the availability of oral hypoglycemic agents due to supply chain problems caused by a disruption in global logistics during the COVID-19 pandemic could impede the revenue growth of pharmaceutical companies operating within Indonesia`s antidiabetic drug industry. The presence Of counterfeit medications within Indonesia markets may lead to consumers being exposed to low-quality or substandard treatments resulting in more severe medical conditions leading to higher financial losses over time. Additionally, since most counterfeits cannot be differentiated from genuine medications without proper testing , it would result into lesser trust amongst customers towards branded manufacturers leading into lower sales potentials down the line.

Key Market Players

Some key players operating within Indonesia`s Antidtibetic Drug Industry include Sanofi S A, Eli Lilly And Company, Novo Nordisk AS, Abbott Laboratories Inc., B Braun Melsungen AG, etc..

Key Highlights of the Report:

  • Indonesia Antidiabetics Market Outlook
  • Market Size of Indonesia Antidiabetics Market, 2020
  • Forecast of Indonesia Antidiabetics Market, 2027
  • Historical Data and Forecast of Indonesia Antidiabetics Revenues & Volume for the Period 2023 - 2027
  • Indonesia Antidiabetics Market Trend Evolution
  • Indonesia Antidiabetics Market Drivers and Challenges
  • Indonesia Antidiabetics Price Trends
  • Indonesia Antidiabetics Porter's Five Forces
  • Indonesia Antidiabetics Industry Life Cycle
  • Historical Data and Forecast of Indonesia Antidiabetics Market Revenues & Volume By Product for the Period 2023 - 2027
  • Historical Data and Forecast of Indonesia Antidiabetics Market Revenues & Volume By Insulin  for the Period 2023 - 2027
  • Historical Data and Forecast of Indonesia Antidiabetics Market Revenues & Volume By Drug Class for the Period 2023 - 2027
  • Historical Data and Forecast of Indonesia Antidiabetics Market Revenues & Volume By Patient Population for the Period 2023 - 2027
  • Historical Data and Forecast of Indonesia Antidiabetics Market Revenues & Volume By Paediatric for the Period 2023 - 2027
  • Historical Data and Forecast of Indonesia Antidiabetics Market Revenues & Volume By Adult for the Period 2023 - 2027
  • Historical Data and Forecast of Indonesia Antidiabetics Market Revenues & Volume By Geriatric for the Period 2023 - 2027
  • Historical Data and Forecast of Indonesia Antidiabetics Market Revenues & Volume By Route of Administration for the Period 2023 - 2027
  • Historical Data and Forecast of Indonesia Antidiabetics Market Revenues & Volume By Insulin syringe/ Insulin pen for the Period 2023 - 2027
  • Historical Data and Forecast of Indonesia Antidiabetics Market Revenues & Volume By Insulin pump for the Period 2023 - 2027
  • Historical Data and Forecast of Indonesia Antidiabetics Market Revenues & Volume By Intravenous infusion for the Period 2023 - 2027
  • Historical Data and Forecast of Indonesia Antidiabetics Market Revenues & Volume By Oral for the Period 2023 - 2027
  • Historical Data and Forecast of Indonesia Antidiabetics Market Revenues & Volume By Others for the Period 2023 - 2027
  • Indonesia Antidiabetics Import Export Trade Statistics
  • Market Opportunity Assessment By Product
  • Market Opportunity Assessment By Patient Population
  • Market Opportunity Assessment By Route of Administration
  • Indonesia Antidiabetics Top Companies Market Share
  • Indonesia Antidiabetics Competitive Benchmarking By Technical and Operational Parameters
  • Indonesia Antidiabetics Company Profiles
  • Indonesia Antidiabetics Key Strategic Recommendations
Frequently Asked Questions About the Market Study (FAQs):
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Indonesia Antidiabetics

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 Indonesia Antidiabetics Market Overview

3.1 Indonesia Country Macro Economic Indicators

3.2 Indonesia Antidiabetics Market Revenues & Volume, 2020 & 2027F

3.3 Indonesia Antidiabetics Market - Industry Life Cycle

3.4 Indonesia Antidiabetics Market - Porter's Five Forces

3.5 Indonesia Antidiabetics Market Revenues & Volume Share, By Product, 2020 & 2027F

3.6 Indonesia Antidiabetics Market Revenues & Volume Share, By Patient Population, 2020 & 2027F

3.7 Indonesia Antidiabetics Market Revenues & Volume Share, By Route of Administration, 2020 & 2027F

4 Indonesia Antidiabetics Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.3 Market Restraints

5 Indonesia Antidiabetics Market Trends

6 Indonesia Antidiabetics Market, By Types

6.1 Indonesia Antidiabetics Market, By Product

6.1.1 Overview and Analysis

6.1.2 Indonesia Antidiabetics Market Revenues & Volume, By Product, 2018 - 2027F

6.1.3 Indonesia Antidiabetics Market Revenues & Volume, By Insulin , 2018 - 2027F

6.1.4 Indonesia Antidiabetics Market Revenues & Volume, By Drug Class, 2018 - 2027F

6.2 Indonesia Antidiabetics Market, By Patient Population

6.2.1 Overview and Analysis

6.2.2 Indonesia Antidiabetics Market Revenues & Volume, By Paediatric, 2018 - 2027F

6.2.3 Indonesia Antidiabetics Market Revenues & Volume, By Adult, 2018 - 2027F

6.2.4 Indonesia Antidiabetics Market Revenues & Volume, By Geriatric, 2018 - 2027F

6.3 Indonesia Antidiabetics Market, By Route of Administration

6.3.1 Overview and Analysis

6.3.2 Indonesia Antidiabetics Market Revenues & Volume, By Insulin syringe/ Insulin pen, 2018 - 2027F

6.3.3 Indonesia Antidiabetics Market Revenues & Volume, By Insulin pump, 2018 - 2027F

6.3.4 Indonesia Antidiabetics Market Revenues & Volume, By Intravenous infusion, 2018 - 2027F

6.3.5 Indonesia Antidiabetics Market Revenues & Volume, By Oral, 2018 - 2027F

6.3.6 Indonesia Antidiabetics Market Revenues & Volume, By Others, 2018 - 2027F

7 Indonesia Antidiabetics Market Import-Export Trade Statistics

7.1 Indonesia Antidiabetics Market Export to Major Countries

7.2 Indonesia Antidiabetics Market Imports from Major Countries

8 Indonesia Antidiabetics Market Key Performance Indicators

9 Indonesia Antidiabetics Market - Opportunity Assessment

9.1 Indonesia Antidiabetics Market Opportunity Assessment, By Product, 2020 & 2027F

9.2 Indonesia Antidiabetics Market Opportunity Assessment, By Patient Population, 2020 & 2027F

9.3 Indonesia Antidiabetics Market Opportunity Assessment, By Route of Administration, 2020 & 2027F

10 Indonesia Antidiabetics Market - Competitive Landscape

10.1 Indonesia Antidiabetics Market Revenue Share, By Companies, 2020

10.2 Indonesia Antidiabetics Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All